Dennis Hess’s research interests are in thin film science and technology, surface and interface modification and characterization, microelectronics processing and electronic materials. His group focuses on the establishment of fundamental structure-property relationships and their connection to chemical process sequences used in the fabrication of novel films, electronic materials, devices, and nanostructures. Control of the surface properties of materials such as dielectrics, semiconductors, metals, and paper or paper board by film deposition or surface modification allows the design of such surfaces for a variety of applications in microelectronics, packaging, sensors, microfluidics, and separation processes.

The Gutekunst Lab is interested in pushing the limits of complexity in macromolecular systems using innovative concepts from synthetic organic chemistry. 

Specific projects in the lab will explore the design of novel monomers for the construction of functional polyamides, the development of small molecule reagents for the dynamic modulation of branched polymer architectures, and the investigation of new concepts for creating covalent bonds in challenging contexts. Each of these research projects will enable the generation of new functional materials with structures or assemblies that were previously inaccessible for study. 

Prospective students will obtain extensive training in synthetic organic chemistry, as well as polymer synthesis and characterization.

Aditi Das did her BSc. (Hons.) Chemistry from St. Stephen's College Delhi, followed by M.S. (Chemistry) from I.I.T (Kanpur). She received her Ph.D. in Chemistry from Princeton University. She did post-doctoral work with Prof. Steve Sligar. She joined University of Illinois, Urbana-Champaign (UIUC) as a tenure track assistant professor in 2012. In 2019, she was promoted to associate professor with tenure. In 2022, she joined School of Chemistry and Biochemistry at Georgia Institute of Technology as an associate professor with tenure. Her research is in the area of enzymology of oxygenases that are involved lipid metabolism and cannabinoid metabolism.

Das is recipient of an American Heart Associate (AHA) career award and has been funded by National Institute of Health (NIH - NIGMS, NIDA and NCCIH), USDA, and National Multiple Sclerosis Society (NMSS). Her research was recognized by several National awards: Young Investigator award From Eicosanoid Research Foundation, Mary Swartz Rose Young Investigator Award and E.L.R. Stokstad award from American Society for Nutrition (ASN) for outstanding research on bioactive compounds for human health. She is also the recipient of Zoetis Research Excellence Award from her college. She was a co-organizer of the International Conference on Cytochrome P450. Recently her laboratory contributed several papers on cannabinoid metabolism by p450s. In recognition of this work, she was awarded El Sohly award from the ACS-Cannabis division for excellence in Cannabis research and is invited to give plenary lecture at ISSX meeting.  Das is also a standing study section member of BBM NIH study section. 

Marilyn Brown is a Regents' and Brook Byers Professor of Sustainable Systems in the School of Public Policy. She joined Georgia Tech in 2006 after a distinguished career at the U.S. Department of Energy's Oak Ridge National Laboratory, where she led several national climate change mitigation studies and became a leader in the analysis and interpretation of energy futures in the United States. 

Her research focuses on the design and impact of policies aimed at accelerating the development and deployment of sustainable energy technologies, with an emphasis on the electric utility industry, the integration of energy efficiency, demand response, and solar resources, and ways of improving resiliency to disruptions. Her books include Fact and Fiction in Global Energy Policy (Johns Hopkins University Press, 2016), Green Savings: How Policies and Markets Drive Energy Efficiency (Praeger, 2015), and Climate Change and Global Energy Security (MIT Press, 2011). She has authored more than 250 publications. Her work has had significant visibility in the policy arena as evidenced by her numerous briefings and testimonies before state legislative bodies and Committees of both the U.S. House of Representatives and Senate.

Dr. Brown co-founded the Southeast Energy Efficiency Alliance and chaired its Board of Directors for several years. She has served on the Boards of the American Council for an Energy-Efficient Economy and the Alliance to Save Energy, and was a commissioner with the Bipartisan Policy Center. She has served on eight National Academies committees and is an Editor of Energy Policy and an Editorial Board member of Energy Efficiency and Energy Research and Social Science. She served two terms (2010-2017) as a Presidential appointee and regulator on the Board of Directors of the Tennessee Valley Authority, the nation’s largest public power provider. From 2014-2018 she served on DOE’s Electricity Advisory Committee, where she led the Smart Grid Subcommittee.

Blair Brettmann received her B.S. in chemical engineering at the University of Texas at Austin in 2007. She received her Master’s in chemical engineering practice from MIT in 2009 following internships at GlaxoSmithKline (Upper Merion, PA) and Mawana Sugar Works (Mawana, India). Blair received her Ph.D. in chemical engineering at MIT in 2012 working with the Novartis-MIT Center for Continuous Manufacturing under Professor Bernhardt Trout. Her research focused on solid-state characterization and application of pharmaceutical formulations prepared by electrospinning. Following her Ph.D., Brettmann worked as a research engineer for Saint-Gobain Ceramics and Plastics for two years. While at Saint-Gobain she worked on polymer-based wet coatings and dispersions for various applications, including window films, glass fiber mats and architectural fabrics. Later, Brettmann served as a postdoctoral researcher in the Institute for Molecular Engineering at the University of Chicago with Professor Matthew Tirrell. Currently, Brettmann is an assistant professor with joint appointments in chemical and biomolecular engineering and Materials Science and Engineering at Georgia Tech.

Dr. Boukouvala is originally from Piraeus, which is the port of Athens in Greece. As the daughter of an airforce pilot, she travelled a lot with her family. Her first international move was actually to the USA, where she spent one year in Montgomery, Alabama. She later on lived in Riyadh, Saudi Arabia and Crete, Greece, before returning to Athens to get her B.S Degree in Chemical Engineering from the National Technical University in Athens. In 2008, she moved back to the US to obtain a PhD in Chemical Engineering at Rutgers University in NJ. She then worked as a Postdoctoral Associate in both Princeton University and Texas A&M University. In August 2016, Dr. Boukouvala returned to the South East US, as an Assistant Professor in the School of Chemical & Biomolecular Engineering at Georgia Tech. 

Her research interest in Process Systems Engineering (PSE) started during her PhD years, where she worked under the supervision of Dr. Marianthi Ierapetritou, on modeling and optimization of continuous pharmaceutical manufacturing. Her background on optimization and data-driven modeling was enhanced during her years as a postdoc with the late Christodoulos A. Floudas. Dr. Boukouvala is a proud 4th generation member of the academic family tree of the father of PSE, Roger Sargent.

Andreas (Andy) S. Bommarius is a professor of Chemical and Biomolecular Engineering as well of Chemistry and Biochemistry at the Georgia Institute of Technology in Atlanta, GA.  He received his diploma in Chemistry in 1984 at the Technical University of Munich, Germany and his Chemical Engineering B.S. and Ph.D. degrees in 1982 and 1989 at MIT, Cambridge, MA.

From 1990-2000, he led the Laboratory of Enzyme Catalysis at Degussa (now Evonik) in Wolfgang, Germany, where his work ranged from immobilizing homogenous catalysts in membrane reactors to large-scale cofactor-regenerated redox reactions to pharma intermediates.

At Georgia Tech since 2000, his research interests cover green chemistry and biomolecular engineering, specifically biocatalyst development and protein stability studies.  His lab applies data-driven protein engineering to improve protein properties on catalysts ranging from ene and nitro reductases to cellobiohydrolases.  Bommarius has guided the repositioning of the curriculum towards Chemical and Biomolecular Engineering by developing new courses in Process Design, Biocatalysis and Metabolic Engineering, as well as Drug Design, Development, and Delivery (D4), an interdisciplinary course with Mark Prausnitz.

Andy Bommarius in 2008 became a Fellow of the American Institute of Medical and Biological Engineering.  Since 2010, he is Director of the NSF-I/UCR Center for Pharmaceutical Development (CPD), a Center focusing on process development, drug substance and product stability, and novel analytical methods for the characterization of drug substances and excipients.

Saad Bhamla studies biomechanics across species to engineer knowledge and tools that inspire curiosity.

Saad Bhamla is an assistant professor of biomolecular engineering at Georgia Tech. A self-proclaimed "tinkerer," his lab is a trove of discoveries and inventions that span biology, physics and engineering. His current projects include studying the hydrodynamics of insect urine, worm blob locomotion and ultra-low-cost devices for global health. His work has appeared in the New York Times, the Economist, CNN, Wired, NPR, the Wall Street Journal and more.

Saad is a prolific inventor and his most notable inventions includes a 20-cent paper centrifuge, a 23-cent electroporator, and the 96-cent hearing aid. Saad's work is recognised by numerous awards including a NIH R35 Outstanding Investigator Award, NSF CAREER Award, CTL/BP Junior Faculty Teaching Excellence Award, and INDEX: Design to Improve Life Award. Saad is also a National Geographic Explorer and a TED speaker. Newsweek recognized Saad as 1 of 10 Innovators disrupting healthcare.

Saad is a co-founder of Piezo Therapeutics.

Outside of the lab, Saad loves to go hiking with his partner and two dogs (Ollie and Bella).